• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCTER & GAMBLE ORAL-B GLIDE PRO HEALTH; FLOSS, DENTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCTER & GAMBLE ORAL-B GLIDE PRO HEALTH; FLOSS, DENTAL Back to Search Results
Health Effect - Clinical Codes Nausea (1970); Malaise (2359)
Date of Event 10/04/2023
Type of Reportable Event Serious Injury
Event or Problem Description
I went for a dental cleaning and i noticed during this cleaning that the hygienist brought an oral b glide pro health brand of dental floss.The hygienist used this brand of dental floss on my teeth and gums.Several minutes later as i drove home i experienced nausea and felt unwell which i never experienced before after a mere dental cleaning procedure.I did an online search and found that this product is known to have extremely high amounts of fluorine, with test results of around 250,000 to 380,000 ppm of fluorine which correlates directly with pfas content.The fda has already determined that pfas are toxic at the parts per quadrillion range so that procter & gamble has the audacity not merely to add pfas to their dental floss but to add such extreme and hazardous concentrations of pfas to their products in nothing short of shocking.My doctor has ordered a pfas blood test through (b)(6), and while i understand that this test only shows the most common pfas, i'm hopefully that whatever pfas used by proctor & gamble will be included in the pfas that are tested by this panel.I do believe that the fda should investigate and determine what pfas were used by p&g not merely because they use pfas in their dental floss products but because of the concentrations.I understand that many products have pfas as indicated by their fluorine content in a range of 1-65 ppm, which although it unacceptable, p&g products presents a pfas hazard several of orders of magnitude greater than typical pfas containing product and because of this should be an agency priority.Again the fact that this product is in the quarter million plus ppm range demonstrates it is an emergent hazard to the public, and that even single exposures by individuals such as myself who was exposed in a dental cleaning and does not buy the product, causes a significant increase in pfas body burden and corresponding significant harm.Again that i experienced acute symptoms after this pfas laden floss was used on me, and moreover lab results of fluorine concentration of this floss, demonstrates this product not only violates fda guidelines concerning use of pfas but also demonstrates the glide brands of p&g floss constitute and acute exposure hazard and does not merely threaten the health of habitual users of the product.The question below asks if i have the product in case the fda needs to evaluate it.My answer is that the prosthodontist office where i had my dental cleaning likely has many/a volume of it in stock and readily on hand.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORAL-B GLIDE PRO HEALTH
Common Device Name
FLOSS, DENTAL
Manufacturer (Section D)
PROCTER & GAMBLE
MDR Report Key17926000
Report NumberMW5146885
Device Sequence Number3295887
Product Code JES
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 10/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date10/11/2023
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age32 YR
Patient SexMale
Patient Weight103 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-